SCHEMBL9260712

SCHEMBL9260712

Cc1ccc(NC(=O)C=C(S)c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.60
RAB9A P51151 6/20 0.60
MAPT P10636 4/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
EGFR P00533 1/20 0.56
MMP1 P03956 1/20 0.56
MMP2 P08253 1/20 0.56
MMP9 P14780 1/20 0.56
DEGS1 O15121 1/20 0.55
NMT1 P30419 1/20 0.54
TGM2 P21980 1/20 0.53
HPGD P15428 1/20 0.51
ALDH1A1 P00352 7/20 0.49
TDP1 Q9NUW8 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
PTGS2 P35354 1/20 0.49
DDAH1 O94760 1/20 0.49
LMNA P02545 1/20 0.48
CCR6 P51684 1/20 0.48
MEN1 O00255 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260709 1.00 NPC1 (0.60) NPC1RAB9AMAPTSMN1; SMN2EGFR
SCHEMBL9256847 0.85 FFAR1 (0.54) NPC1RAB9AMAPTDEGS1TGM2
SCHEMBL9256850 0.85 FFAR1 (0.54) NPC1RAB9AMAPTDEGS1TGM2
SCHEMBL28620583 0.83 NPC1 (0.58) NPC1RAB9AMAPTSMN1; SMN2EGFR
SCHEMBL10954608 0.80 NPC1 (0.55) NPC1RAB9AMAPTSMN1; SMN2EGFR
SCHEMBL9258078 0.80 ALDH1A1 (0.54) MAPTSMN1; SMN2EGFRMMP1MMP2
SCHEMBL9258086 0.80 ALDH1A1 (0.54) MAPTSMN1; SMN2EGFRMMP1MMP2
SCHEMBL10952758 0.79 EGFR (0.54) NPC1RAB9AMAPTSMN1; SMN2EGFR
SCHEMBL11795731 0.78 CES2 (0.55) NPC1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL28522658 0.76 EGFR (0.51) NPC1RAB9AMAPTSMN1; SMN2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5411977-A Substituted 2,5-diaryl-4-isothiazolin-3-ones as antiinflammatory and antithrombotic agents THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-05-02 US disclosed